Poster Abstract Session:
118. Pediatric Antimicrobial Stewardship
Friday, October 4, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Tracks: Pediatric ID

Presentations:

872
Assessment of Appropriate Rapid Streptococcal Antigen Testing in an Urban Pediatric Emergency Department
Kayron Bradley, MD ; Sarah Weston, MD ; Brian Lee, MPH, PhD ; Rangaraj Selvarangan, PhD ; Angela Myers, MD, MPH

873
Adherence to Guidelines for Management of Pharyngitis in Children
Thea Brennan-Krohn, MD ; Al Ozonoff, PhD ; John Graef, MD ; Thomas J. Sandora, MD, MPH

874
To be or not to be a UTI: An Opportunity for Antimicrobial Stewardship in a Pediatric Hospital
Nicole Le Saux, MD ; Annie Pouliot, Pharm D ; Régis Vaillancourt, Pharm D ; Nicholas Barrowman, PHD ; Mary Aglipay, MSc(c) ; Janusz Feber, MD ; Anne K. Rowan-Legg, MD ; Jennifer Bowes, MSc

875
Effects of Race on Otitis Media Diagnosis and Antibiotic Prescribing in Children — United States, 2008–10
Katherine Fleming-Dutra, MD ; Daniel J. Shapiro, BA ; Lauri Hicks, DO ; Jeffrey S. Gerber, MD, PhD ; Adam L. Hersh, MD, PhD

876
Impact of IDSA/PIDS Guidelines on Treatment of Community-Acquired Pneumonia in Hospitalized Children
Rachael Ross, MPH ; Adam L. Hersh, MD, PhD ; Matthew Kronman, MD, MSCE ; Jason Newland, MD ; A. Russell Localio, PhD ; Theoklis Zaoutis, MD, MSCE ; Jeffrey S. Gerber, MD, PhD
Posters
  • CAP Poster v0.7.png (756.2 kB)

  • 877
    Declines in Broad-spectrum Antimicrobial Prescribing for Children Hospitalized with Community-Acquired Pneumonia following Publication of a National Guideline
    Derek J. Williams, MD, MPH ; Kathryn Edwards, MD, FIDSA ; Wesley H. Self, MD, MPH ; Yuwei Zhu, MD, MS ; Krow Ampofo, MD ; Andrew Pavia, MD, FIDSA, FSHEA ; Adam L. Hersh, MD, PhD ; Sandra R. Arnold, MD ; Jonathan A. Mccullers, MD ; Lauri A. Hicks, DO ; Anna M. Bramley, MPH ; Seema Jain, MD ; Carlos G. Grijalva, MD, MPH

    878
    Characterization and Outcomes of Short-Course Antibiotic Treatment for Hospital-Acquired/Ventilator-Associated Pneumonia (HAP/VAP) in Pediatric Patients
    Diana Yu, PharmD, BCPS ; Brian Lee, MPH, PhD ; Leslie Stach, PharmD, BCPS ; Jason Newland, MD ; Jennifer Goldman, MD
    Posters
  • IDSA VAP Poster.pdf (324.9 kB)

  • 879
    A Quality Improvement (QI) Initiative To Decrease Inappropriate Utilization Of Antibiotics In RSV: A Team Approach Towards Antimicrobial Stewardship
    Sejal Makvana, MD ; Leonard Krilov, MD ; Maria Lyn Quintos-Alagheband, MD ; Gladys El-Chaar, PharmD

    881
    Impact of Antimicrobial Stewardship in a Network of Freestanding Children's Hospitals
    Adam L. Hersh, MD, PhD ; Cary Thurm, PhD ; Jason Newland, MD ; Scott Weissman, MD ; Matthew Kronman, MD, MSCE ; Samir Shah, MD, MSCE ; Joshua Courter, PharmD ; Jeffrey S. Gerber, MD, PhD

    883
    Antimicrobial Resistance Patterns of Bloodstream Infections in Hospitalized Children
    Beatriz Larru, MD, PhD ; Neika Vendetti, MPH ; Kaede Ota, MD ; Theoklis Zaoutis, MD, MSCE ; Pranita D. Tamma, MD, MHS ; Ritu Banerjee, MD, PhD ; Jeffrey S. Gerber, MD, PhD

    884
    Outpatient Parenteral Antimicrobial Therapy (OPAT) in Pediatrics: Descriptive Analysis of Adverse Events in Pediatric OPAT to Identify Areas for Quality and Patient Safety Improvement
    Jennifer Murphy, BA ; Norman Fenn, BSc ; Heather Heizer, PA-C ; Shannon Hughes, PA ; Jason Child, PharmD ; Sarah Parker, MD
    Posters
  • Murphy IDSA poster 884.pdf (10.0 MB)

  • 885
    Variation in Antibiotic Prescribing Practices among Nurse Practitioners (NPs) in a Pediatric Urgent Care Center (UCC)
    Gina Weddle, DNP, RN, CPNP ; J. Christopher Day, MD ; Jennifer Goldman, MD ; Angela Myers, MD, MPH ; Jason Newland, MD ; Leslie Stach, PharmD, BCPS ; Diana Yu, PharmD, BCPS

    886
    Outpatient parenteral antibiotic therapy in pediatrics: An opportunity to expand antimicrobial stewardship
    Elizabeth Doby, MD ; Carly Davis, MD ; Andrew Pavia, MD, FIDSA, FSHEA ; Chris Stockmann, MSc ; Emily A. Thorell, MD, MSci ; Adam L. Hersh, MD, PhD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.